Related Experiment Video

Updated: Jul 2, 2026

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Hypoxia downregulates Ku70/80 expression in cervical carcinoma tumors

Pedro Carlos Lara1, Marta Lloret, Bernardino Clavo

  • 1Radiation Oncology, Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Spain. plara@dcc.ulpgc.es

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|August 19, 2008
PubMed

Insights

Hypoxia may hinder non-homologous end joining (NHEJ) DNA repair by reducing Ku70/80 expression. This, along with increased angiogenesis and altered p53, likely drives cervical cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cervical carcinoma is a significant global health concern.
  • Tumor progression involves complex genetic and molecular alterations.
  • DNA repair mechanisms play a crucial role in maintaining genomic stability.

Purpose of the Study:

  • To investigate the impact of hypoxia on DNA repair pathways in cervical cancer.
  • To explore the relationship between hypoxia, Ku70/80 expression, angiogenesis, and p53 in cervical carcinoma.
  • To elucidate the molecular mechanisms underlying tumor progression in cervical cancer under hypoxic conditions.

Main Methods:

  • Analysis of Ku70/80 expression in cervical cancer tissues.
  • Assessment of angiogenesis markers.
  • Evaluation of p53 expression patterns.
  • Correlation studies between hypoxia, DNA repair, and tumor progression indicators.

Main Results:

  • Hypoxia was found to inhibit non-homologous end joining (NHEJ) DNA repair.
  • This inhibition is associated with downregulated Ku70/80 expression.
  • Increased angiogenesis and altered p53 expression were observed in conjunction with these changes.
  • These molecular events are linked to cervical carcinoma progression.

Conclusions:

  • Hypoxia-induced downregulation of Ku70/80 impairs NHEJ DNA repair in cervical cancer.
  • The combination of impaired DNA repair, enhanced angiogenesis, and altered p53 contributes to tumor progression.
  • Targeting these pathways may offer novel therapeutic strategies for cervical carcinoma.

More Related Videos

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...